B.s.n. Biological Sales Networks.r.l.

B.s.n. Biological Sales Networks.r.l. is a company in Castelleone, Italy that has taken part in 2 EU-funded projects since 2023, receiving €71k in EU funding.

EU funding received€71k
EU projects2
As coordinator0
Running now2
First EU project2023
Latest project2027
CountryItaly
EU registration (PIC)894209536
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are B.s.n. Biological Sales Networks.r.l.'s own share of each project, not the project's full budget.

  • Horizon Europe€71k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • INNOVATOCPartner

    Innovative exploitation of PVAT-vascular crosstalk through integrated tissue biology, animal models, and organ-on-chip to deliver clinically validated ASCVD biomarkers

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €16ktheir share
  • CardioSCOPEPartner

    Comprehensive and personalized assessment of acute coronary syndrome by multiomic approach and artificial intelligence strategy

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €55ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • amorphous semiconductors
  • genetics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime